The maker of Darvon and Darvocet have announced on Friday that it will stop marketing the painkillers in the U.S. because of a new study that links the active ingredient in the drugs to serious and sometimes fatal heart rhythm abnormalities. Xanodyne Pharmaceuticals Inc. have agreed to the ban at the request of the Food and Drug Administration (FDA)... continue reading at Dr. OP Garg, Senior Consultant Rheumatologist in New Delhi, India talks about Arthritis and other joint treatments

In resistant cases of RA,  injectable biologics which include Enbrel, Humira, and Remicade can cost as much as $1,500 a month and carry a risk of infection. The new pill of  Tasocitinib is given orally, and if approved, it will become the first new oral drug for rheumatoid arthritis since Arava was okayed in the late... continue reading at Dr. OP Garg, Senior Consultant Rheumatologist in New Delhi, India talks about Arthritis and other joint treatments